R J BIO-TECH | BOMBAY BURMAH | R J BIO-TECH/ BOMBAY BURMAH |
|||
---|---|---|---|---|---|
P/E (TTM) | x | - | -167.2 | - | View Chart |
P/BV | x | - | 2.7 | - | View Chart |
Dividend Yield | % | 0.0 | 0.1 | - |
R J BIO-TECH BOMBAY BURMAH |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
R J BIO-TECH Mar-22 |
BOMBAY BURMAH Mar-23 |
R J BIO-TECH/ BOMBAY BURMAH |
5-Yr Chart Click to enlarge
|
||
High | Rs | 12 | 1,116 | 1.1% | |
Low | Rs | 5 | 781 | 0.7% | |
Sales per share (Unadj.) | Rs | 14.7 | 2,382.5 | 0.6% | |
Earnings per share (Unadj.) | Rs | -4.3 | -110.6 | 3.9% | |
Cash flow per share (Unadj.) | Rs | -4.2 | -76.3 | 5.5% | |
Dividends per share (Unadj.) | Rs | 0 | 1.20 | 0.0% | |
Avg Dividend yield | % | 0 | 0.1 | 0.0% | |
Book value per share (Unadj.) | Rs | -53.2 | 578.1 | -9.2% | |
Shares outstanding (eoy) | m | 9.47 | 69.77 | 13.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 0.4 | 146.1% | |
Avg P/E ratio | x | -2.0 | -8.6 | 23.3% | |
P/CF ratio (eoy) | x | -2.0 | -12.4 | 16.3% | |
Price / Book Value ratio | x | -0.2 | 1.6 | -9.8% | |
Dividend payout | % | 0 | -1.1 | 0.0% | |
Avg Mkt Cap | Rs m | 81 | 66,154 | 0.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 6 | 7,693 | 0.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 139 | 166,229 | 0.1% | |
Other income | Rs m | 7 | 4,559 | 0.1% | |
Total revenues | Rs m | 146 | 170,789 | 0.1% | |
Gross profit | Rs m | 12 | 2,513 | 0.5% | |
Depreciation | Rs m | 1 | 2,393 | 0.0% | |
Interest | Rs m | 58 | 4,253 | 1.4% | |
Profit before tax | Rs m | -40 | 427 | -9.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 8,142 | 0.0% | |
Profit after tax | Rs m | -40 | -7,715 | 0.5% | |
Gross profit margin | % | 8.4 | 1.5 | 555.1% | |
Effective tax rate | % | 0 | 1,907.9 | -0.0% | |
Net profit margin | % | -29.1 | -4.6 | 627.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 3 | 84,148 | 0.0% | |
Current liabilities | Rs m | 484 | 54,411 | 0.9% | |
Net working cap to sales | % | -345.9 | 17.9 | -1,933.3% | |
Current ratio | x | 0 | 1.5 | 0.4% | |
Inventory Days | Days | 3 | 117 | 2.2% | |
Debtors Days | Days | 7,265,677 | 86 | 8,474,464.4% | |
Net fixed assets | Rs m | 16 | 72,183 | 0.0% | |
Share capital | Rs m | 95 | 140 | 67.8% | |
"Free" reserves | Rs m | -598 | 40,195 | -1.5% | |
Net worth | Rs m | -503 | 40,335 | -1.2% | |
Long term debt | Rs m | 33 | 42,709 | 0.1% | |
Total assets | Rs m | 19 | 156,779 | 0.0% | |
Interest coverage | x | 0.3 | 1.1 | 27.7% | |
Debt to equity ratio | x | -0.1 | 1.1 | -6.2% | |
Sales to assets ratio | x | 7.2 | 1.1 | 683.0% | |
Return on assets | % | 92.4 | -2.2 | -4,182.3% | |
Return on equity | % | 8.0 | -19.1 | -42.0% | |
Return on capital | % | -3.8 | 5.6 | -66.9% | |
Exports to sales | % | 0 | 0.4 | 0.0% | |
Imports to sales | % | 2.5 | 0.1 | 1,995.1% | |
Exports (fob) | Rs m | NA | 604 | 0.0% | |
Imports (cif) | Rs m | 4 | 210 | 1.7% | |
Fx inflow | Rs m | 0 | 604 | 0.0% | |
Fx outflow | Rs m | 4 | 210 | 1.7% | |
Net fx | Rs m | -4 | 394 | -0.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -47 | 24,737 | -0.2% | |
From Investments | Rs m | NA | -13,339 | -0.0% | |
From Financial Activity | Rs m | 47 | -11,614 | -0.4% | |
Net Cashflow | Rs m | 0 | -116 | 0.3% |
Indian Promoters | % | 60.3 | 55.9 | 107.8% | |
Foreign collaborators | % | 0.0 | 18.1 | - | |
Indian inst/Mut Fund | % | 0.0 | 10.2 | - | |
FIIs | % | 0.0 | 9.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 39.7 | 26.0 | 152.9% | |
Shareholders | 245 | 32,500 | 0.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare R J BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | R J BIO-TECH | BOM.BURMAH | S&P BSE FMCG |
---|---|---|---|
1-Day | 0.59% | 0.52% | 0.11% |
1-Month | 1.48% | -2.20% | 1.53% |
1-Year | -26.39% | 51.60% | 14.09% |
3-Year CAGR | -24.59% | 10.22% | 15.86% |
5-Year CAGR | -25.99% | 4.90% | 10.81% |
* Compound Annual Growth Rate
Here are more details on the R J BIO-TECH share price and the BOM.BURMAH share price.
Moving on to shareholding structures...
The promoters of R J BIO-TECH hold a 60.3% stake in the company. In case of BOM.BURMAH the stake stands at 74.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of R J BIO-TECH and the shareholding pattern of BOM.BURMAH.
Finally, a word on dividends...
In the most recent financial year, R J BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
BOM.BURMAH paid Rs 1.2, and its dividend payout ratio stood at -1.1%.
You may visit here to review the dividend history of R J BIO-TECH, and the dividend history of BOM.BURMAH.
For a sector overview, read our fmcg sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.